Other languages Structure Therapeutics Inc.

Equities

GPCR

US86366E1064

Market Closed - Nasdaq Other stock markets 04:00:00 2024-07-08 pm EDT			5-day change	1st Jan Change
37.23 ^USD	-1.43%		-6.92%	-8.66%

Jun. 27	Structure Therapeutics Inc. Appoints Ted W. Love as to the Audit Committee	CI
Jun. 07	Structure Therapeutics Closes $547.4 Million Offering	MT

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Structure Therapeutics Inc. Appoints Ted W. Love as to the Audit Committee	Jun. 27
Structure Therapeutics Closes $547.4 Million Offering	Jun. 07
Structure Therapeutics Prices Upsized $476 Million Stock Offering	Jun. 06
Structure Therapeutics Plans Offering of American Depositary Shares	Jun. 03
Top Midday Gainers	Jun. 03
Sector Update: Health Care Stocks Edge Higher Monday Afternoon	Jun. 03
Structure Therapeutics Reports Positive Topline Data From Obesity Trial; Shares Jump	Jun. 03
Structure Therapeutics' obesity drug meets main goal in mid-stage study	Jun. 03
Structure Therapeutics Inc. Reports Positive Topline Data from its Phase 2a Obesity Study and Capsule to Tablet PK Study for its Oral Non-Peptide Small Molecule GLP-1 Receptor Agonist GSBR-1290	Jun. 03
Structure Therapeutics Inc. Announces Ramy Farid Not Standing for Re-Election to Board of Directors, Term Expire on June 25, 2024	May. 30
Structure Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 09
Structure Therapeutics Q4 Loss Widens	Mar. 08
Structure Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 08
Structure Therapeutics Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 08
Structure Therapeutics Shares Tumble After Update on GSBR-1290 for Weight Loss	Dec. 18
Structure's diabetes pill misses weight-loss expectations in mid-stage trial	Dec. 18
Structure Therapeutics Inc. Provides Comprehensive GSBR-1290 Program Update	Dec. 18
Structure Therapeutics Q3 Loss Narrows	Nov. 14
Structure Therapeutics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14
Sector Update: Health Care Stocks Lower Late Afternoon	23-09-29

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Structure Therapeutics Inc.

Equities

GPCR

US86366E1064

Other languages

Filters